STE · 10-Q · 2026Q3 · Full report

Capital Expenditures and Free Cash Flow

STERIS plc · 2026-11-05 · Importance 49 · Surprise 32 · From source text

For the first six months of fiscal 2027, operating cash flow was $656.1 million and free cash flow was $492.5 million, down from $707.8 million and $527.7 million, respectively, a year earlier. The decreases reflected a lower working-capital contribution as the company used cash to build inventory, partly offset by higher net income. Capital expenditures were $163.6 million, compared with $180.1 million in the prior-year period, with the decrease attributed to the timing of spending.

Key facts

• STERIS incurred capital expenditures of $163.6 million in the first six months of fiscal 2027, down from $180.1 million in the prior-year period due to the timing of capital spending. source
• STERIS operating cash flow was $656.1 million and free cash flow was $492.5 million for the first six months of fiscal 2027, versus $707.8 million and $527.7 million, respectively, in fiscal 2026; the decrease resulted from lower working-capital contribution as cash was used to build inventory, partly offset by higher net income. source
• STERIS free cash flow was $492.5 million for the six months ended September 30, 2026, calculated from $656.1 million of operating cash flow less $163.6 million of purchases of property, plant, equipment and intangibles. source
• STERIS used $184.6 million in investing activities in the first six months of fiscal 2027, compared with $196.8 million in fiscal 2026. source
• STERIS intends to use existing cash and cash equivalents and cash generated from operations for short- and long-term capital expenditures and other liquidity needs. source

Impact estimates